Literature DB >> 1889874

Treatment of a meningitis due to an Enterobacter aerogenes producing a derepressed cephalosporinase and a Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.

C de Champs1, D Guelon, D Joyon, D Sirot, M Chanal, J Sirot.   

Abstract

A case of nosocomial meningitis due to a Klebsiella pneumoniae producing a CAZ-5 extended-spectrum beta-lactamase and an Enterobacter aerogenes producing a derepressed cephalosporinase is reported. The intrathecal catheter incriminated was removed and a treatment with ceftazidime (4 g/24 h) and amikacin (1.5 g/24 h) was started. After 24 h ceftazidime was replaced by imipenem (2 then 4 g/24 h). This treatment failed to obtain cerebrospinal fluid sterilization; therefore the imipenem dosage was increased to 8 g/24 h and two intrathecal infusions of amikacin (50 mg) were carried out. Thereafter the patient recovered.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1889874     DOI: 10.1007/bf01643247

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  12 in total

1.  Intrathecal baclofen for intractable spasticity due to severe brain injury.

Authors:  L Saltuari; E Schmutzhard; M Kofler; H Baumgartner; F Aichner; F Gerstenbrand
Journal:  Lancet       Date:  1989-08-26       Impact factor: 79.321

2.  The safety profile of imipenem/cilastatin: worldwide clinical experience based on 3470 patients.

Authors:  G B Calandra; C Wang; M Aziz; K R Brown
Journal:  J Antimicrob Chemother       Date:  1986-12       Impact factor: 5.790

3.  Penetration of imipenem and cilastatin into cerebrospinal fluid of patients with bacterial meningitis.

Authors:  J Modai; D Vittecoq; J M Decazes; A Meulemans
Journal:  J Antimicrob Chemother       Date:  1985-12       Impact factor: 5.790

4.  A new plasmidic cefotaximase in a clinical isolate of Escherichia coli.

Authors:  A Bauernfeind; H Grimm; S Schweighart
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

5.  Substrate-labeled fluorescent immunoassay for amikacin in human serum.

Authors:  S G Thompson; J F Burd
Journal:  Antimicrob Agents Chemother       Date:  1980-08       Impact factor: 5.191

6.  Treatment failures of cefotaxime and latamoxef in meningitis caused by Enterobacter and Serratia spp.

Authors:  R H Eng; C E Cherubin; J C Pechere; T R Beam
Journal:  J Antimicrob Chemother       Date:  1987-12       Impact factor: 5.790

7.  Comparative study of five plasmid-mediated ceftazidimases isolated in Klebsiella pneumoniae.

Authors:  D Sirot; C Chanal; R Labia; M Meyran; J Sirot; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1989-10       Impact factor: 5.790

8.  Antibacterial activities of a new stabilized thienamycin, N-formimidoyl thienamycin, in comparison with other antibiotics.

Authors:  T Kesado; T Hashizume; Y Asahi
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins.

Authors:  A Bauernfeind; Y Chong; S Schweighart
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

10.  Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit.

Authors:  C Brun-Buisson; P Legrand; A Rauss; C Richard; F Montravers; M Besbes; J L Meakins; C J Soussy; F Lemaire
Journal:  Ann Intern Med       Date:  1989-06-01       Impact factor: 25.391

View more
  6 in total

1.  Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or -resistant Enterobacter cloacae strains.

Authors:  O Mimoz; A Jacolot; S Leotard; N Hidri; K Samii; P Nordmann; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1998-12       Impact factor: 5.191

Review 2.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

3.  Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit.

Authors:  C Arpin; C Coze; A M Rogues; J P Gachie; C Bebear; C Quentin
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Selective digestive decontamination by erythromycin-base in a polyvalent intensive care unit.

Authors:  C L de Champs; D P Guelon; R M Garnier; M C Poupart; O Y Mansoor; F L Dissait; J L Sirot
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

Review 5.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

6.  Molecular epidemiological study of nosocomial Enterobacter aerogenes isolates in a Belgian hospital.

Authors:  S Jalaluddin; J M Devaster; R Scheen; M Gerard; J P Butzler
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.